The University of Chicago Header Logo

Connection

Rolf Barth to Antibodies, Neoplasm

Back to Details
This is a "connection" page, showing publications Rolf Barth has written about Antibodies, Neoplasm.
Rolf Barth
Connection Strength
0.273
Antibodies, Neoplasm
  1. Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation. Transpl Int. 2006 Nov; 19(11):885-92.
    View in: PubMed
    Score: 0.273
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.